The GID Group, Inc. is a consortium of world-leading plastic surgeons, adipose tissue scientists, and seasoned entrepreneurial managers that use a deep science-based approach to create a reliable, cost-effective tissue processing platform that enables a broad range of therapies based on regenerative cells derived from human tissue. Our technology separates and concentrates the regenerative fraction of cells from the tissues in real-time in the operating room, enabling therapeutic application in a single surgical treatment.
A new type of therapeutic medicine is emerging where the patient’s own cells are used in an entirely natural way to repair or regenerate tissues or control pain/inflammation. Cell-based therapies are based on use of a patient’s own regenerative cells, including adult stem cells, which must be extracted from the patient’s tissues and concentrated to achieve a therapeutic result.
http://thegidgroup.com distributor in Taiwan and Hong Kong.
Company’s Keywords:
regenerative medicine, aesthetic medicine, plastic surgery, svf, adsc, gid
2
medical devices
2013
Your request has been submitted successfully.
Own or work here?